Incidence, treatments, and outcomes of SARS-CoV-2 and HIV co-infections
Journal of Global Health Reports
; 5(e2021099), 2021.
Article
in English
| CAB Abstracts | ID: covidwho-1865741
ABSTRACT
Background:
We investigated the global threat of co-infection of severe acute respiratory coronavirus 2 (SARS-CoV-2) to patients living with another prevalent viral infection HIV. We have analyzed symptom status, treatment, and outcome of co-infected individuals.
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Pesticides and Drugs; Control [HH405]; viral diseases; human immunodeficiency viruses; human diseases; HIV infections; coronavirus disease 2019; people living with HIV; drug therapy; antiretroviral agents; infections; mixed infections; disease incidence; medical treatment; treatment outcomes; epidemiology; world; symptoms; antiviral agents; tenofovir; emtricitabine; multiple drug therapy; public health; comorbidity; Severe acute respiratory syndrome coronavirus 2; man; Lentivirus; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Orthoretrovirinae; Retroviridae; RNA Reverse Transcribing Viruses; viral infections; SARS-CoV-2; human immunodeficiency virus infections; chemotherapy; multiple infections; worldwide; antivirals; combination drug therapy
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Observational study
Language:
English
Journal:
Journal of Global Health Reports
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS